Home Investors Mubadala Capital Ventures

Mubadala Capital Ventures

Active VC

Portfolio Active

Deal flow

$30M

1 round

Unicorns

≥ $1B valuation

Founded

—

Latest

—

Tahoe Therapeutics

About Mubadala Capital Ventures

Venture capital firm tracking 1 AI investment, with focus on Drug Discovery. Total tracked deal flow: $30M.

Tahoe Therapeutics, formerly Vevo Therapeutics, builds gigascale single-cell datasets to train